A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men.
The effects of consuming a soy protein isolate beverage powder (60 g/d for 28 d) vs. a casein supplement was evaluated in 20 male subjects who were randomly allocated into the two groups. A dramatic rise in plasma isoflavone concentrations was observed after supplementation in the soy protein group, the levels reaching 907 +/- 245 nmol/L for genistein (a 110-fold increase) and 498 +/- 102 nmol/L for daidzein (a 150-fold increase) as measured by isotope dilution gas chromatography - mass spectrometry. These concentrations are higher than previously reported for the plasma of Japanese subjects consuming a traditional diet (276 nmol/L and 107 nmol/L, respectively). No significant differences in collagen- or 9,11-dideoxy-11alpha, 9alpha-epoxymethanoprostaglandin F2alpha (U46619)-induced platelet aggregation were observed in platelet-rich plasma from the two groups; the increase in plasma isoflavonoids from soy protein supplementation is not sufficient to significantly inhibit platelet aggregation ex vivo. Similarly, plasma total and HDL-cholesterol were not affected by protein supplementation, possibly because the men were normocholesterolemic at entry. Analysis of plasma phospholipid polyunsaturated fatty acid composition showed no differences between soy protein and casein supplementation. Previous investigations reported a significant alteration in fatty acid status in animals fed soy protein relative to those fed casein. The present studies indicate that although soy protein supplementation to a typical Western diet can increase plasma concentrations of isoflavones, this may not necessarily be sufficient to counter heart disease risk factors such as high plasma cholesterol and platelet aggregation.
Gooderham
M H
MH
Department of Human Biology and Nutritional Sciences, University of Guelph, Ontario, Canada.
Adlercreutz
H
H
Ojala
S T
ST
Wähälä
K
K
Holub
B J
BJ
D000328:Adult; D002364:Caseins / Q000494:pharmacology; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D003094:Collagen / Q000494:pharmacology; D004968:Estrogens, Non-Steroidal / Q000097:blood; D005227:Fatty Acids / Q000032:analysis; D008401:Gas Chromatography-Mass Spectrometry; D019833:Genistein; D006801:Humans; D007529:Isoflavones / Q000032:analysis* / Q000097:blood* / Q000494:pharmacology; D008055:Lipids / Q000097:blood*; D008297:Male; D010743:Phospholipids / Q000097:blood / Q000737:chemistry*; D048789:Phytoestrogens; D028321:Plant Preparations; D014674:Plant Proteins, Dietary / Q000737:chemistry / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects*; D030262:Soybean Proteins
D002364:Caseins; D008076:Cholesterol, HDL; D004968:Estrogens, Non-Steroidal; D005227:Fatty Acids; D007529:Isoflavones; D008055:Lipids; D010743:Phospholipids; D048789:Phytoestrogens; D028321:Plant Preparations; D014674:Plant Proteins, Dietary; D030262:Soybean Proteins; C004742:daidzein; D003094:Collagen; D002784:Cholesterol; D019833:Genistein